慢性肺病谱系中胸部CT肺动脉扩张与肺动脉高压的关联
该研究在PVDOMICS队列中测量252例慢性肺病患者的CT肺动脉直径和PA/A比值,评估其与右心导管测得的肺动脉高压的关联。结果显示PA大小与PH存在关联,检测能力中等,且关联强度因病因不同而异,在间质性肺病中最弱。
要点
- CT肺动脉直径和PA/A比值与慢性肺病患者的PH相关,检测能力中等。
- PA/A与mPAP的关联在非实质组最强,在间质组最弱。
- 间质组PA/A诊断性能低于阻塞组和非实质组。
核心结论
- CT肺动脉大小与慢性肺病中第3组PH的存在相关,按当代诊断标准具有中等检测能力。
- 关联因疾病病因不同而异,在间质性肺病中最弱。
研究设计与样本
- 在PVDOMICS队列中测量所有第3组PH患者及对照者的CT肺动脉直径和PA/A比值。
- 患者分为阻塞性、间质性或非实质亚组,通过右心导管测量mPAP。
- 共纳入252例患者(阻塞性n=81;间质性n=125;非实质n=46)。
- 使用多变量线性回归、逻辑回归和ROC曲线分析评估关联和诊断性能。
主要发现
- PA大小与PH相关(直径:OR 4.30;Q3 vs Q1,2.32-8.00;PA/A:OR 5.66;Q3 vs Q1,2.86-11.18)。
- PA大小与mPAP相关(直径:ρ=0.516;PA/A:ρ=0.494;P<.001)。
- 检测PH的AUC:直径为0.794,PA/A为0.765。
- PA/A与mPAP的关联在非实质组最强(ρ=0.750),在间质组最弱(ρ=0.373)。
- 间质组PA/A的AUC为0.704,低于阻塞组(0.865)和非实质组(0.822)。
关键数值与推荐
- PA直径Q3 vs Q1与PH的OR为4.30(95%CI 2.32-8.00)。
- PA/A Q3 vs Q1与PH的OR为5.66(95%CI 2.86-11.18)。
- PA直径检测PH的AUC为0.794,PA/A为0.765。
- 间质组PA/A的AUC为0.704,阻塞组为0.865,非实质组为0.822。
- Q1与Q3 mPAP之间的PA扩张:间质组3.9 mm(95%CI 2.3-5.4),阻塞组4.9 mm(95%CI 2.4-7.4),非实质组4.8 mm(95%CI 1.8-7.8)。
临床怎么用
- CT测量的肺动脉大小可作为慢性肺病患者PH的提示指标,但检测能力中等。
- 在间质性肺病患者中,PA/A比值对PH的提示价值较低,需谨慎解读。
局限性
- 需要进一步研究确定影响慢性肺病患者肺动脉扩张性变化的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary artery (PA) dilation on CT scan has been associated with pulmonary hypertension (PH) in patients without lung disease using outdated PH criteria. The relationship between PA size and PH in chronic lung disease is unclear. RESEARCH QUESTION: Is PA size associated with PH in patients with chronic lung disease, and does association differ by disease etiology? STUDY DESIGN AND METHODS: PA diameter and pulmonary artery to aorta ratio (PA/A) were measured on CT scan for all patients with group 3 PH and comparators in the PVDOMICS cohort. Patients were categorized into obstructive, interstitial, or nonparenchymal subgroups. Mean pulmonary artery pressure (mPAP) was measured on right heart catheterization. Associations and diagnostic performance were assessed using multivariable linear and logistic regression and receiver operating curve analysis. RESULTS: Among 252 patients (obstructive: n = 81; interstitial: n = 125; nonparenchymal: n = 46), PA size was associated with PH (diameter: OR, 4.30; Q3 vs Q1, 2.32-8.00; PA/A: OR, 5.66; Q3 vs Q1, 2.86-11.18) and mPAP (diameter: ρ = 0.516; PA/A: ρ = 0.494; P < .001) and possessed moderate ability to detect PH (area under the curve [AUC], 0.794 for diameter; AUC, 0.765 for PA/A). The association between PA/A and mPAP was strongest in the nonparenchymal group (ρ = 0.750) and weakest in the interstitial group (ρ = 0.373). PA/A diagnostic performance was lower in the interstitial group (AUC, 0.704) compared with the obstructive group (AUC, 0.865) and the nonparenchymal group (AUC, 0.822). PA dilation between Q1 and Q3 mPAP was lower in the interstitial group (3.9 mm; 95% CI, 2.3-5.4) compared with the obstructive (4.9 mm; 95% CI, 2.4-7.4) and nonparenchymal (4.8 mm; 95% CI, 1.8-7.8) groups. INTERPRETATION: Our results show that PA size on CT scan associates with the presence of PH in chronic lung disease and possesses moderate ability to detect group 3 PH by contemporary diagnostic criteria. The association differs by disease etiology and is weakest in interstitial disease. Further work is needed to determine mechanisms influencing variable PA distensibility in patients with chronic lung disease. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT02980887; URL: www. CLINICALTRIALS: gov.
引用
- Couch TJ, Beck GJ, Rosenzweig EB, et al. Pulmonary Artery Dilation on Chest CT Scan Across the Spectrum of Chronic Lung Disease. Chest. 2026. PMID: 42785424. doi:10.1016/j.chest.2026.08.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。